Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Cancer Genetics and Cytogenetics

Volumn 189, Issue 1, 2009, Pages 29-36

  Wehrli, Lea A ^a   Braun, Julia ^b   Buetti, Luisa Nobile ^c   Hagleitner, Nicole ^d   Hengartner, Heinz ^e   Kühne, Thomas ^f   Lüer, Sonja ^g   Ozsahin, Hulya ^h   Popovic, Maja Beck ⁱ   Niggli, Felix K ^a   Betts, David R ^j   Bourquin, Jean Pierre ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Ospedale Regionale di Locarno   (Switzerland)

^d CHILDREN S HOSPITAL   (Switzerland)

^e Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

^f UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

ⁱ Centre Hospitalier Universitaire Vaudois   (Switzerland)

^j OUR LADY S CHILDREN S HOSPITAL   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 7; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 9; CONTROLLED STUDY; EVENT FREE SURVIVAL; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; RELAPSE;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INFANT; KARYOTYPING; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 58249138632     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.10.002     Document Type: Article

References (31)

1. Mrozek K., Heerema N.A., and Bloomfield C.D. Cytogenetics in acute leukemia. Blood Rev 18 (2004) 115-136
2. Harrison C.J., and Foroni L. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev Clin Exp Hematol 6 (2002) 91-113
3. Secker-Walker L.M., Chessells J.M., Stewart E.L., Swansbury G.J., Richards S., and Lawler S.D. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. Br J Haematol 72 (1989) 336-342
4. Trueworthy R., Shuster J., Look T., Crist W., Borowitz M., Carroll A., Frankel L., Harris M., Wagner H., Haggard M., Mosijczuk A., Pullen J., Steuber P., and Land V. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 10 (1992) 606-613
5. Heerema N.A., Nachman J.B., Sather H.N., Sensel M.G., Lee M.K., Hutchinson R., Lange B.J., Steinherz P.G., Bostrom B., Gaynon P.S., and Uckun F. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood 94 (1999) 4036-4045
6. Gibbons B., MacCallum P., Watts E., Rohatiner A.Z., Webb D., Katz F.E., Secker-Walker L.M., Temperley I.J., Harrison C.J., Campbell R.H., Nash R., Broadbent V., and Chessels J.M. Near haploid acute lymphoblastic leukemia: seven new cases and a review of the literature. Leukemia 5 (1991) 738-743
7. Seeger K., Adams H.P., Buchwald D., Beyermann B., Kremens B., Niemeyer C., Ritter J., Schwabe D., Harms D., Schrappe M., and Henze G. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Munster Study Group. Blood 91 (1998) 1716-1722
8. Secker-Walker L.M., Prentice H.G., Durrant J., Richards S., Hall E., and Harrison G. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol 96 (1997) 601-610
9. Arico M., Valsecchi M.G., Camitta B., Schrappe M., Chessells J., Baruchel A., Gaynon P., Silverman L., Janka-Schaub G., Kamps W., Pui C.H., and Masera G. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 342 (2000) 998-1006
10. Pui C.H., Chessells J.M., Camitta B., Baruchel A., Biondi A., Boyett J.M., Carroll A., Eden O.B., Evans W.E., Gadner H., Harbott J., Harms D.O., Harrison C.J., Harrison P.L., Heerema N., Janka-Schaub G., Kamps W., Masera G., Pullen J., Raimondi S.C., Richards S., Riehm H., Sallan S., Sather H., Shuster J., Silverman L.B., Valsecchi M.G., Vilmer E., Zhou Y., Gaynon P.S., and Schrappe M. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 17 (2003) 700-706
11. Heerema N.A., Sather H.N., Sensel M.G., Liu-Mares W., Lange B.J., Bostrom B.C., Nachman J.B., Steinherz P.G., Hutchinson R., Gaynon P.S., Arthur D.C., and Uckun F.M. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 94 (1999) 1537-1544
12. Hann I., Vora A., Harrison G., Harrison C., Eden O., Hill F., Gibson B., and Richards S. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 113 (2001) 103-114
13. Bertin R., Acquaviva C., Mirebeau D., Guidal-Giroux C., Vilmer E., and Cave H. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 37 (2003) 44-57
14. Strefford J.C., Worley H., Barber K., Wright S., Stewart A.R., Robinson H.M., Bettney G., van Delft F.W., Atherton M.G., Davies T., Griffiths M., Hing S., Ross F.M., Talley P., Saha V., Moorman A.V., and Harrison C.J. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene 26 (2007) 4306-4318
15. van Zutven L.J., van Drunen E., de Bont J.M., Wattel M.M., Den Boer M.L., Pieters R., Hagemeijer A., Slater R.M., and Beverloo H.B. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia. Leukemia 19 (2005) 1281-1284
16. Mirebeau D., Acquaviva C., Suciu S., Bertin R., Dastugue N., Robert A., Boutard P., Mechinaud F., Plouvier E., Otten J., Vilmer E., and Cave H. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica 91 (2006) 881-885
17. Attarbaschi A., Mann G., Panzer-Grumayer R., Rottgers S., Steiner M., Konig M., Csinady E., Dworzak M.N., Seidel M., Janousek D., Moricke A., Reichelt C., Harbott J., Schrappe M., Gadner H., and Haas O.A. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. J Clin Oncol 26 (2008) 3046-3050
18. Moorman A.V., Richards S.M., Robinson H.M., Strefford J.C., Gibson B.E., Kinsey S.E., Eden T.O., Vora A.J., Mitchell C.D., and Harrison C.J. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood 109 (2007) 2327-2330
19. Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E., Dalton J.D., Girtman K., Mathew S., Ma J., Pounds S.B., Su X., Pui C.H., Relling M.V., Evans W.E., Shurtleff S.A., and Downing J.R. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446 (2007) 758-764
20. Heerema N.A., Palmer C.G., Weetman R., and Bertolone S. Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia. Leukemia 6 (1992) 185-192
21. Vora A.J., Potter A.M., Anderson L.M., and Lilleyman J.S. Frequency and importance of change in blast cell karyotype in relapsing childhood lymphoblastic leukemia. Pediatric hematology and oncology 11 (1994) 379-386
22. Gaynon P.S., Qu R.P., Chappell R.J., Willoughby M.L., Tubergen D.G., Steinherz P.G., and Trigg M.E. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse-the Children's Cancer Group Experience. Cancer 82 (1998) 1387-1395
23. Chessells J.M., Veys P., Kempski H., Henley P., Leiper A., Webb D., and Hann I.M. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 123 (2003) 396-405
24. Einsiedel H.G., von Stackelberg A., Hartmann R., Fengler R., Schrappe M., Janka-Schaub G., Mann G., Hahlen K., Gobel U., Klingebiel T., Ludwig W.D., and Henze G. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. J Clin Oncol 23 (2005) 7942-7950
25. Malempati S., Gaynon P.S., Sather H., La M.K., and Stork L.C. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952. J Clin Oncol 25 (2007) 5800-5807
26. Shaffer L.G., and Tommerup N. ISCN 2005: An International System for Human Cytogenetic Nomenclature (2005) (2005), S. Karger AG, Basel
27. Gaynon P.S. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 131 (2005) 579-587
28. Akasaka T., Balasas T., Russell L.J., Sugimoto K.J., Majid A., Walewska R., Karran E.L., Brown D.G., Cain K., Harder L., Gesk S., Martin-Subero J.I., Atherton M.G., Bruggemann M., Calasanz M.J., Davies T., Haas O.A., Hagemeijer A., Kempski H., Lessard M., Lillington D.M., Moore S., Nguyen-Khac F., Radford-Weiss I., Schoch C., Struski S., Talley P., Welham M.J., Worley H., Strefford J.C., Harrison C.J., Siebert R., and Dyer M.J. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109 (2007) 3451-3461
29. Russell L.J., Akasaka T., Majid A., Sugimoto K.J., Loraine Karran E., Nagel I., Harder L., Claviez A., Gesk S., Moorman A.V., Ross F., Mazzullo H., Strefford J.C., Siebert R., Dyer M.J., and Harrison C.J. t(6;14)(p22;q32): a new recurrent IGHα translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 111 (2008) 387-391
30. Walker L.C., Morrison M.J., Parfitt R., and Crossen P.E. Translocation (2;14) associated with complex rearrangements of the Ig heavy chain in non-Hodgkin lymphoma. Cancer Genet Cytogenet 128 (2001) 137-140
31. Flohr T., Schrauder A., Cazzaniga G., Panzer-Grumayer R., van der Velden V., Fischer S., Stanulla M., Basso G., Niggli F.K., Schafer B.W., Sutton R., Koehler R., Zimmermann M., Valsecchi M.G., Gadner H., Masera G., Schrappe M., van Dongen J.J., Biondi A., and Bartram C.R. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia (2008) 1-12